Interleukin-12. Biologic activity, therapeutic utility, and role in disease - PubMed (original) (raw)
Affiliations
- PMID: 7783421
Review
Interleukin-12. Biologic activity, therapeutic utility, and role in disease
J A Hendrzak et al. Lab Invest. 1995 Jun.
Abstract
IL-12 is a heterodimeric cytokine that promotes cell-mediated immunity through its regulatory effects on T and NK cells. In some murine infectious disease models, IL-12 was shown to be produced endogenously in response to infection, and the exogenous administration of IL-12 to mice with either infectious diseases or tumors has resulted in significant therapeutic effects. IL-12 was protective early in the disease process, as well as against established disease. However, the biologic activities of IL-12 that are beneficial in the host response to these infectious diseases and malignancies can also be deleterious in certain disease states. Thus, IL-12 has considerable potential for the treatment of a variety of human disorders if used under the appropriate conditions. Likewise, antagonists of IL-12 may have a role in controlling diseases with pathologies that are mediated through immune mechanisms.
Similar articles
- Interleukin-12: potential role in cancer therapy.
Brunda MJ, Gately MK. Brunda MJ, et al. Important Adv Oncol. 1995:3-18. Important Adv Oncol. 1995. PMID: 7672811 Review. - Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases.
Gately MK, Gubler U, Brunda MJ, Nadeau RR, Anderson TD, Lipman JM, Sarmiento U. Gately MK, et al. Ther Immunol. 1994 Jun;1(3):187-96. Ther Immunol. 1994. PMID: 7584494 Review. - [The potential of interleukin-12 for use in cancer therapy].
Gately MK, Brunda MJ. Gately MK, et al. Gan To Kagaku Ryoho. 1996 Jul;23(8):961-71. Gan To Kagaku Ryoho. 1996. PMID: 8687231 Review. Japanese. - Interleukin-12, an emerging anti-tumour cytokine.
Hiscox S, Jiang WG. Hiscox S, et al. In Vivo. 1997 Mar-Apr;11(2):125-32. In Vivo. 1997. PMID: 9179604 Review. - Interleukin-12: biological properties and clinical application.
Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A. Del Vecchio M, et al. Clin Cancer Res. 2007 Aug 15;13(16):4677-85. doi: 10.1158/1078-0432.CCR-07-0776. Clin Cancer Res. 2007. PMID: 17699845 Review.
Cited by
- Evaluation of an ImmunoPET Tracer for IL-12 in a Preclinical Model of Inflammatory Immune Responses.
Viola NT, Glassbrook JE, Kalluri JR, Hackett JB, Wicker MN, Sternberg J, Gibson HM. Viola NT, et al. Front Immunol. 2022 May 11;13:870110. doi: 10.3389/fimmu.2022.870110. eCollection 2022. Front Immunol. 2022. PMID: 35634303 Free PMC article. - Acute White Matter Tract Damage after Frontal Mild Traumatic Brain Injury.
Herrera JJ, Bockhorst K, Kondraganti S, Stertz L, Quevedo J, Narayana PA. Herrera JJ, et al. J Neurotrauma. 2017 Jan 15;34(2):291-299. doi: 10.1089/neu.2016.4407. Epub 2016 Jun 20. J Neurotrauma. 2017. PMID: 27138134 Free PMC article. - Serum interleukin 8 and 12 levels predict severity and mortality in patients with alcoholic hepatitis.
Patel OP, Noor MT, Kumar R, Thakur BS. Patel OP, et al. Indian J Gastroenterol. 2015 May;34(3):209-15. doi: 10.1007/s12664-015-0565-4. Epub 2015 Jun 26. Indian J Gastroenterol. 2015. PMID: 26108651 - Prenatal maternal anxiety predicts reduced adaptive immunity in infants.
O'Connor TG, Winter MA, Hunn J, Carnahan J, Pressman EK, Glover V, Robertson-Blackmore E, Moynihan JA, Lee FE, Caserta MT. O'Connor TG, et al. Brain Behav Immun. 2013 Aug;32:21-8. doi: 10.1016/j.bbi.2013.02.002. Epub 2013 Feb 21. Brain Behav Immun. 2013. PMID: 23439080 Free PMC article. - Effect of malnutrition on the expression of cytokines involved in Th1 cell differentiation.
González-Torres C, González-Martínez H, Miliar A, Nájera O, Graniel J, Firo V, Alvarez C, Bonilla E, Rodríguez L. González-Torres C, et al. Nutrients. 2013 Feb 19;5(2):579-93. doi: 10.3390/nu5020579. Nutrients. 2013. PMID: 23429441 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources